WO2011011843A1 - Método químico para esterilização sexual e eliminação da libido em mamíferos do sexo masculino - Google Patents
Método químico para esterilização sexual e eliminação da libido em mamíferos do sexo masculino Download PDFInfo
- Publication number
- WO2011011843A1 WO2011011843A1 PCT/BR2010/000207 BR2010000207W WO2011011843A1 WO 2011011843 A1 WO2011011843 A1 WO 2011011843A1 BR 2010000207 W BR2010000207 W BR 2010000207W WO 2011011843 A1 WO2011011843 A1 WO 2011011843A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- libido
- animals
- mammals
- elimination
- male
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Definitions
- This invention relates to a non-therapeutic biological treatment method for sexual sterilization and libido elimination and is intended for male mammals such as bovine, ovine, caprine, canine, domestic feline, equine, swine, and man having testicles. in the scrotum.
- the method is based on the injection into the cranial surface of the testis of a sterile aqueous solution containing active ingredients with sclerosing (lactic acid; 20-70%) and enzymatic (papain; 05-20%) functions that results in loss of organ fibrillation. gametogenic and androgenic function.
- Orchiectomy removal of the testicles
- castration of ruminant males is necessary for several reasons, the main ones being the decrease in aggressiveness, facilitating the management and reducing the risk of injury to man and other animals; elimination of libido with longer time dedicated to food, resulting in greater weight gain; avoid the risk of undesirable coverings by males with low genetic potential, and provide better quality carcasses due to higher fat accumulation and higher proportion of noble meat when compared to whole animals.
- the methods usually used in the castration process are based, in the vast majority of cases, on surgery that consists of the removal of the testicles or the use of emasculators, instruments that promote smashing of the spermatic cord resulting in the interruption of the testicular blood flow, with to promote organ atrophy.
- tannic zinc (Fahim et al., 1982), glycerol (Weinbauer et al., 1985, Immegart 2000), glucose, NaCl (Heath et al., 1987, Russell, 1987 et al.) DBCP (Shemi et al. 1988 ), lactic acid (Fordyce et al. 1989), arginine zinc (Fahim et al. 1993), sodium fluoride (Sprando et al. 1996), phonnalin (Balar et al. 2002) and chlorinated calcium (Samanta 1998, Jana et al. 2002), glacial acetic potassium permanganate (Giri et al. 2002).
- the use of the emasculator requires proper training by the operator, as otherwise there may be complications that may mitigate the need for a surgical intervention, which may result in the death of the animal.
- the aim of the present invention is to provide a safe method of biological castration for the animal and the operator that addresses the problems presented by animals subjected to the processes cited in the prior art
- the method consists in the intratesticular application of a sclerosing solution composed of biological active ingredients (papain extracted from papaya and lactic acid extracted from milk), which once performed promotes an inflammatory reaction with subsequent fibrillation and elimination of gametogenic and androgenic testicular functions, resulting in sexual sterilization and loss of libido.
- the invention is based on the association of the papain enzyme at a concentration of 2 to 10% with the lactic acid solution at a concentration of 20 to 80% in a sterile aqueous solution which, once applied to the testis, triggers a more inflammatory reaction. acute with faster resolution, resulting in greater treatment efficiency, as the enzyme facilitates the diffusion of acid. Anticipated resolution of the inflammatory process implies less discomfort due to the edema presented by the treated animals. Assessments performed to assess the physiological and behavioral parameters that characterize pain during and immediately after intratesticular solution administration such as changes in heart and respiratory rates, vocalization, look or lick application site and prolonged decubitus have shown that the animals did not expressed that feeling.
- testicular parenchyma is poorly innervated, concentrating these nerve structures in the scrotum.
- Testicular fibrillation the final phase of the process, leads to the loss of its gametogenic and androgenic function. Parallel to this, the animals that received the indicated dosage showed no undesirable systemic reactions (fever, decreased appetite and weight loss) and no local reactions (hyperthermia, abscesses and necrosis).
- One of the great advantages of the created method is that, because it is a "closed” procedure, the possibility of environmental contamination is practically non-existent, allowing that, unlike the surgical method, it can be performed independently of the year (rainy season). or pasture conditions (flooded or planted areas that may cause irritation or bleeding from the surgical wound) that may trigger infections, myiasis and tetanus; which would result in losses with spending on medicines, labor and weight loss in the affected animals.
- the application of the sterilizing biological solution should be performed after previous scrotal pouch asepsis, being applied a volume ranging from 0.2 (feline) to 20 ml (bovine and equine) in each testis, in its cranial portion, therefore not requiring , great skill of the technician who performs it, requiring only a short demonstrative training to the operator.
- There is no fixed correlation between species, patient weight, testicular diameter and applied dose which is defined by the reaction of the organ to the same, characterized by the contraction of every organ during application, which indicates that the solution has reached the whole. therefore, at this time the application is discontinued.
- the product has been shown to be harmless to humans and has not caused irritation, blemishes, itching or any other undesirable reaction when in contact with the operator's skin. Due to this feature, it is not necessary, therefore, the use of gloves or mask, since the product does not present strong odor that can cause any respiratory discomfort. Handwashing after application is recommended, although as the aqueous vehicle, the degree of absorption is small, and if this occurs, both active principles do not report in the literature citing them as causing poisoning. human being. Lactic acid is a physiological product present in the mammalian organism, being a metabolite of glycogenolysis papain would only become harmful if it was inhaled as a powder in large quantities, resulting in lung problems. Still regarding the latter, it is It is used in edible products such as meat tenderizers and is therefore well tolerated by the human body when ingested in small quantities.
- Testicular edema was maximum within 48 hours of application, fully regressing within 60 days. In the first 24 hours after application, the animals no longer showed signs of libido or aggression. On the other hand, the animals submitted to surgery presented a longer period of suffering, until the surgical wound had healed, around 15 to 20 days; as some were affected by myiasis and infections, requiring return to management centers to undergo nursing procedures such as application of local and systemic antibiotics and repellents, resulting in these maneuvers in more stressful situations. None of the treated animals showed return of libido, and there was no need for a second application of the drug.
- Organ fragments were collected by sampling and, after histopathological exams, no injury to the cardiac, pulmonary, hepatic and renal function, which proves the safety of the product to animals at the recommended dose.
- the testis samples analyzed demonstrated a focal necrosis process, with total loss of sperm and testosterone producing function, given the destruction of their production sites, seminiferous tubules and Sertoli cells, respectively. It is noteworthy that this loss of function was not limited to the areas where focal necrosis was observed, but throughout the testicular parenchyma, including the areas apparently normal to macroscopic examination.
- the recommended period for slaughtering treated animals is at least 12 months after application.
- the aforementioned experiment was promoted the early slaughter for operational issues of the property where it was performed. It is estimated that, with the extension of this period, the gains in slaughterhouse indices tend to be higher than those obtained by animals undergoing the surgical process.
- animals undergoing surgical procedures were susceptible to various complications already mentioned, requiring return to the management centers to receive nursing care, those who underwent the biological process of the present invention only returned to the same. to be heavy and have the condition of the testicles and their general condition evaluated. Under normal conditions, for biologically treated animals, there is no need to return them to management centers; which results in less stress, with consequent increase in feed conversion rate and weight gain.
- the sterilizing biological solution was applied to approximately 2000 cattle, 80 sheep, 70 goats, 10 pigs, 15 horses, 16 dogs and eight cats. Libido return was observed in about 5% of treated animals. In these animals a second application was performed to obtain the desired effect. This practice is recommended for animals that continue to show signs of libido after 15 days from the date of application.
- the literature cites the maintenance of the practice of the horse as part of a conditioned behavior, observed in about 30% of the animals submitted to surgical castration, having no relation with the testosterone levels.
- the described solution has the advantages of not triggering signs of pain when properly applied, thus helping to comply with international standards aimed at protecting animals against procedures that cause suffering and, when applied to farm animals, eliminates the grace period between application and consumption of the meat of these animals, making it safe for humans to consume it.
- This new method discourages breeders from using hormones as an alternative to the risks of the surgical process, providing a product from animals that have not been subjected to wasted management practices, highly valued by first-world countries and those of Muslim religion. Due to the fact that the solution consists of biological active principles, biosecurity is preserved, since if there is no contamination of the meat there will be no contamination of the environment with any residues present in the body secretions of the treated animals.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PH12012500162A PH12012500162A1 (en) | 2009-07-28 | 2010-01-25 | Chemical method for sexual sterilization and libido elimination in male mammals |
| NZ597924A NZ597924A (en) | 2009-07-28 | 2010-06-14 | CHEMICAL METHOD FOR SEXUAL STERILISATION AND LIBIDO SUPPRESSION IN MALE MAMMALS using lactic acid and papain |
| CA2768404A CA2768404A1 (en) | 2009-07-28 | 2010-06-14 | Chemical method for sexual sterilization and libido elimination in male mammals |
| CN2010800320531A CN102497878A (zh) | 2009-07-28 | 2010-06-14 | 在雄性哺乳动物中性绝育和性欲阻遏的化学方法 |
| US13/387,196 US20120156188A1 (en) | 2009-07-28 | 2010-06-14 | Chemical method for sexual sterilization and libido elimination in male mammals |
| AU2010278687A AU2010278687A1 (en) | 2009-07-28 | 2010-06-14 | Chemical method for sexual sterilisation and libido suppression in male mammals |
| JP2012521911A JP2013500273A (ja) | 2009-07-28 | 2010-06-14 | 哺乳動物の雄における不妊化およびリビドー抑制のための化学的方法 |
| RU2012106488/15A RU2012106488A (ru) | 2009-07-28 | 2010-06-14 | Химический способ половой стерилизации и устранения полового влечения у самцов млекопитающих |
| MX2012000503A MX2012000503A (es) | 2009-07-28 | 2010-06-14 | Metodo quimico para esterilizacion sexual y eliminacion de libido en mamiferos machos. |
| EP10803747.4A EP2460532A4 (en) | 2009-07-28 | 2010-06-14 | CHEMICAL PROCESS FOR SEXUAL STERILIZATION AND REMOVAL OF LIBIDO IN MAMMALS OF MALE SEX |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0902699-1A BRPI0902699A2 (pt) | 2009-07-28 | 2009-07-28 | método quìmico para esterilização sexual e eliminação da libido em mamìferos do sexo masculino |
| BRPI0902699-1 | 2009-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2011011843A1 true WO2011011843A1 (pt) | 2011-02-03 |
Family
ID=43528649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/BR2010/000207 Ceased WO2011011843A1 (pt) | 2009-07-28 | 2010-06-14 | Método químico para esterilização sexual e eliminação da libido em mamíferos do sexo masculino |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120156188A1 (pt) |
| EP (1) | EP2460532A4 (pt) |
| JP (1) | JP2013500273A (pt) |
| KR (1) | KR20120052355A (pt) |
| CN (1) | CN102497878A (pt) |
| AU (1) | AU2010278687A1 (pt) |
| BR (1) | BRPI0902699A2 (pt) |
| CA (1) | CA2768404A1 (pt) |
| CO (1) | CO6491066A2 (pt) |
| MX (1) | MX2012000503A (pt) |
| NZ (1) | NZ597924A (pt) |
| PH (1) | PH12012500162A1 (pt) |
| RU (1) | RU2012106488A (pt) |
| WO (1) | WO2011011843A1 (pt) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2568364C1 (ru) * | 2014-06-26 | 2015-11-20 | Государственное Научное Учреждение Научно-исследовательский институт ветеринарии Восточной Сибири Россельхозакадемии | Способ для кастрации самцов сельскохозяйственных животных |
| EA026326B1 (ru) * | 2014-05-23 | 2017-03-31 | Елена Владимировна Кухар | Препарат для химической кастрации бычков |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101360830B1 (ko) | 2013-11-21 | 2014-02-11 | (주)나비바이오텍 | 젖산을 함유한 동물의 난소 기능 불활 조성물 |
| KR102249104B1 (ko) | 2019-04-30 | 2021-05-07 | (주)인벤티지랩 | 데슬로렐린을 포함하는 서방성 마이크로 입자 및 이의 제조 방법 |
| KR20230124229A (ko) | 2022-02-18 | 2023-08-25 | (주)인벤티지랩 | 데슬로렐린을 포함하는 서방성 주사용 조성물 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4156427A (en) * | 1976-01-23 | 1979-05-29 | The Curators Of The University Of Missouri | Injectable male animal sterilant for selectively controlling the function of testes |
| US4339438A (en) * | 1976-01-23 | 1982-07-13 | The Curators Of The University Of Missouri | Injectable male animal sterilant for selectively controlling the function of testes |
| US4356189A (en) * | 1979-04-13 | 1982-10-26 | Philips, Roxane, Inc. | Chemical castration |
| US5164181A (en) * | 1992-01-14 | 1992-11-17 | Robert E. Hopkins, Ii, D.V.M., Inc. | Enzyme castration of animals |
| RU2198669C2 (ru) * | 2000-12-27 | 2003-02-20 | Галочкин Владимир Анатольевич | Способ энзимостерилизации животных |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3122440A (en) * | 1961-05-02 | 1964-02-25 | Hodges Res & Dev Co | Processes of tenderizing meat using ante-mortem enzyme injection and post-mortem water injection |
| WO1998042862A1 (fr) * | 1997-03-21 | 1998-10-01 | Snow Brand Milk Products Co., Ltd. | Hydrolysat du complexe fer-caseine et son procede de production |
| CA2240079A1 (en) * | 1998-07-20 | 2000-01-20 | Cyril Gallant | Method for preparing a stuffed lobster product incorporating protease enzyme and vacuum extracted meat and roe from head-shells of raw lobster |
-
2009
- 2009-07-28 BR BRPI0902699-1A patent/BRPI0902699A2/pt not_active Application Discontinuation
-
2010
- 2010-01-25 PH PH12012500162A patent/PH12012500162A1/en unknown
- 2010-06-14 EP EP10803747.4A patent/EP2460532A4/en not_active Withdrawn
- 2010-06-14 JP JP2012521911A patent/JP2013500273A/ja not_active Abandoned
- 2010-06-14 CA CA2768404A patent/CA2768404A1/en not_active Abandoned
- 2010-06-14 US US13/387,196 patent/US20120156188A1/en not_active Abandoned
- 2010-06-14 WO PCT/BR2010/000207 patent/WO2011011843A1/pt not_active Ceased
- 2010-06-14 NZ NZ597924A patent/NZ597924A/xx not_active IP Right Cessation
- 2010-06-14 KR KR1020127005134A patent/KR20120052355A/ko not_active Withdrawn
- 2010-06-14 MX MX2012000503A patent/MX2012000503A/es not_active Application Discontinuation
- 2010-06-14 AU AU2010278687A patent/AU2010278687A1/en not_active Abandoned
- 2010-06-14 RU RU2012106488/15A patent/RU2012106488A/ru unknown
- 2010-06-14 CN CN2010800320531A patent/CN102497878A/zh active Pending
-
2012
- 2012-01-20 CO CO12008129A patent/CO6491066A2/es not_active Application Discontinuation
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4156427A (en) * | 1976-01-23 | 1979-05-29 | The Curators Of The University Of Missouri | Injectable male animal sterilant for selectively controlling the function of testes |
| US4339438A (en) * | 1976-01-23 | 1982-07-13 | The Curators Of The University Of Missouri | Injectable male animal sterilant for selectively controlling the function of testes |
| US4356189A (en) * | 1979-04-13 | 1982-10-26 | Philips, Roxane, Inc. | Chemical castration |
| US5164181A (en) * | 1992-01-14 | 1992-11-17 | Robert E. Hopkins, Ii, D.V.M., Inc. | Enzyme castration of animals |
| RU2198669C2 (ru) * | 2000-12-27 | 2003-02-20 | Галочкин Владимир Анатольевич | Способ энзимостерилизации животных |
Non-Patent Citations (1)
| Title |
|---|
| FORDYCE ET AL.: "An evaluation of calf castration by intra-testicular injection of a lactic acid solution", AUST. VET. J., vol. 66, 1989, pages 272 - 276, XP008151894 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA026326B1 (ru) * | 2014-05-23 | 2017-03-31 | Елена Владимировна Кухар | Препарат для химической кастрации бычков |
| RU2568364C1 (ru) * | 2014-06-26 | 2015-11-20 | Государственное Научное Учреждение Научно-исследовательский институт ветеринарии Восточной Сибири Россельхозакадемии | Способ для кастрации самцов сельскохозяйственных животных |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2768404A1 (en) | 2011-02-03 |
| CN102497878A (zh) | 2012-06-13 |
| PH12012500162A1 (en) | 2011-02-03 |
| EP2460532A4 (en) | 2013-05-15 |
| KR20120052355A (ko) | 2012-05-23 |
| MX2012000503A (es) | 2012-08-03 |
| BRPI0902699A2 (pt) | 2011-04-12 |
| US20120156188A1 (en) | 2012-06-21 |
| RU2012106488A (ru) | 2013-09-10 |
| JP2013500273A (ja) | 2013-01-07 |
| CO6491066A2 (es) | 2012-07-31 |
| AU2010278687A1 (en) | 2012-02-23 |
| EP2460532A1 (en) | 2012-06-06 |
| NZ597924A (en) | 2012-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Anderson et al. | Pain management in cattle | |
| Teixeira et al. | Comparison of intrarectal ozone, ozone administered in acupoints and meloxicam for postoperative analgesia in bitches undergoing ovariohysterectomy | |
| Boden | Black's veterinary dictionary | |
| Becker et al. | Acute and chronic pain in calves after different methods of rubber-ring castration | |
| WO2011011843A1 (pt) | Método químico para esterilização sexual e eliminação da libido em mamíferos do sexo masculino | |
| Jesse et al. | Clinical management of severe cutaneous myiasis in a brangus-cross calf | |
| Eales et al. | Practical lambing and lamb care: a veterinary guide | |
| RU2473338C1 (ru) | Способ лечения и профилактики бабезиоза северных оленей | |
| ES2991426T3 (es) | Composición para uso en el tratamiento de la enfermedad de la fiebre actosa (FMD), boquera (ORF), picornavirus, parapoxvirus y una enfermedad patógena que causa lesiones de viruela | |
| Fekry et al. | Assessment of a multimodal analgesia protocol in goats undergoing claw amputation | |
| HK1166612A (en) | Chemical method for sexual sterilisation and libido suppression in male mammals | |
| Saylak et al. | Surgical Treatment of Coccygeal Fractures in Fat-Tailed Sheep. | |
| Puri et al. | Intratesticular injection of calcium chloride is a useful alternative for neutering the male dog | |
| Hilliard et al. | Post‐partum paralysis following dystocia in a miniature horse | |
| RU2722162C1 (ru) | Способ лечения травм сухожильно-связочного аппарата у лошадей | |
| RU2097028C1 (ru) | Препарат для лечения субклинических эндометритов | |
| Скляров | Development of protocols and efficiency of ozone-containing drugs for the treatment of livestock with reproductive pathologies | |
| PAOLINI et al. | 8-A CLINICAL EVALUATION OF TWO DIFFERENT VOLUMES OF EPIDURAL ANAESTHESIA IN CALVES UNDERGOING CASTRATION | |
| Houpt | Veterinary care | |
| Banerjee et al. | Diagnosis and management of cutaneous bovine papillomatosis | |
| RU2132680C1 (ru) | Способ лечения тимпании рубца | |
| RU2406484C1 (ru) | Способ лечения смещения сычуга | |
| De Silva | Sedative analgesic effects of detomidine HCl (Domosedan) in Lanka buffaloes | |
| Blackwell | Reducing distress in swine: why, when and how. | |
| Hempstead et al. | 2 Chapter 2 Cautery disbudding of goat kids: Less painful alternatives and pain mitigation can improve goat welfare |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 201080032053.1 Country of ref document: CN |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10803747 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2012/000503 Country of ref document: MX |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2768404 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 664/CHENP/2012 Country of ref document: IN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 12008129 Country of ref document: CO |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2012000200 Country of ref document: CL |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 12012500162 Country of ref document: PH |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 13387196 Country of ref document: US |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2012521911 Country of ref document: JP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1201000288 Country of ref document: TH |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2010278687 Country of ref document: AU |
|
| ENP | Entry into the national phase |
Ref document number: 2010278687 Country of ref document: AU Date of ref document: 20100614 Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: A201202053 Country of ref document: UA Ref document number: 2010803747 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 20127005134 Country of ref document: KR Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2012106488 Country of ref document: RU |
|
| REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012002161 Country of ref document: BR |
|
| ENPW | Started to enter national phase and was withdrawn or failed for other reasons |
Ref document number: 112012002161 Country of ref document: BR |